Interview with Björn von Siemens, Co-Founder of caresyntax




WHO, Germany open hub for pandemic and epidemic intelligence in Berlin

New hub’s mission is to provide the world with better data, analytics and decisions to detect and respond to health emergencies


Chancellor Merkel and WHO Director-General Tedros open international hub for pandemic preparedness on Wednesday in Berlin

Invitation to join the virtual press conference on the opening of the WHO Hub for Pandemic and Epidemic Intelligence


atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update


-Successfully completed Initial Public Offering on Nasdaq raising $258.8 million in gross proceeds, including the underwriters’ over-allotment-

-Received $20 million upfront payment from Otsuka as part of the first major collaboration between a…


Nobelpharma signs a License Agreement for ProBioGen’s Vaccine Manufacturing Platform AGE1.CR.pIX®


ProBioGen is pleased to announce that Nobelpharma has signed a license agreement for the use of the AGE1.CR.pIX vaccine production platform to develop their lead vaccine. The signing of the agreement is yet another milestone in a series of fruitful…


Eckert & Ziegler Takes over Brazilian Isotope Specialists - Strengthening their Presence in South America


Berlin, 2 August 2021. Eckert & Ziegler (ISIN DE0005659700, TecDAX) acquired Ambientis Radioproteção, based in Sao Paulo, Brazil, effective July 31st, 2021 via its subsidiary Eckert & Ziegler Brasil Isotope Solutions Ltda (EZBIS). The business with…


BIOTRONIK’s Implantable Cardiac Monitor Receives Prestigious Industry Award

BIOMONITOR IIIm Received Frost & Sullivan’s ‘Enabling Technology Leadership Award’ 2021 for its High Precision Cardiac Monitoring


Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through Clinical Trials


– Seventure Partners and Novartis Pharmaceuticals join as new investors

– Transformative treatment for millions of children with myopia

Berlin, Germany, July 14, 2021 — Dopavision, a company pioneering the development of digital therapeutics,…


City of Hope takes a Commercial Product License to use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform


Berlin, Germany and Duarte, USA, June 9, 2021:

ProBioGen AG has announced a commercial product license agreement with City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening…

Show more items